BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Sagittarius season will end during the winter solstice. The sun will leave the centaur for the sea-goat on December 21, 2024, ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...

This new species exhibits several unique traits, including specific structural differences in its ribs and vertebrae, such as ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Oklahoma City Repertory Theater is staging the regional premiere of Larissa FastHorse's hit holiday comedy Nov. 7-17.

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

“Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review and Meta-analysis” highlights the efficacy and safety of iTNM for treating UUI and ...